Fiche centre
Peters Medical Research
High Point — United States
Essais liés4clinical trials
VilleHigh Pointlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07116499
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| K-645 100 mg | Migraine | Phase 2 | NCT07116499 | A Study of K-645 in the Treatment of Multiple Migraine Attacks | TERMINATED |
| Elismetrep (K-304) 2 mg | Migraine | Phase 2 | NCT06848075 | A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine | COMPLETED |
| Dihydroergotamine | Migraine | Phase 3 | NCT04940390 | SUMMIT — A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine | COMPLETED |
| TNX-1900 | Migraine | Phase 2 | NCT05679908 | PREVENTION — A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine | COMPLETED |